Braftovi (encorafenib)

Braftovi (encorafenib)

Braftovi

Encorafenib

Capsules- 50 mg and 75 mg

Array BioPharma

Medical Use

Medical Uses – BRAFTOVI is a kinase inhibitor indicated, in combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.

WhatsApp Chat